Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012
In 2011–2012, 29 EU/EEA Member States and Croatia participated in the first EU-wide, ECDC-coordinated point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals. Data from a total of 273 753 patients in 1149 hospitals were submitted to ECDC in order to estimate the prevalence of healthcare-associated infections in European hospitals.
This report presents the findings of that survey, together with data on antimicrobial use in those hospitals, and makes some proposals for ways to maximise the prevention of infections and antimicrobial resistance in European healthcare institutions.
Summary: Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012
Questions and answers: Point prevalence survey of healthcare-associated infections and antimicrobial use in European hospitals 2011–2012
The first Europe-wide point prevalence survey on healthcare-associated infections and antimicrobial use estimates that on any given day, about 80 000 patients – or one in 18 patients – in European hospitals have at least one healthcare-associated infection.
Conducted in more than 1 000 hospitals in 30 European countries, the survey provides the most comprehensive database on healthcare-associated infections and antimicrobial use in European acute care hospitals to date. The data are published as a report and also available online as an interactive database.
The data report and the database include data on the most commonly reported healthcare-associated infections and involved microorganisms, how often and for which indications antimicrobial drugs are being used and indicators on infection control structures and processes in European hospitals. The prevalence of healthcare-associated infections is the highest among patients admitted to intensive care units (ICUs). The most common types of such infections are respiratory tract infections, surgical site infections, urinary tract infections and bloodstream infections. At least one in three patients, receive at least one antimicrobial agent on any given day in European hospitals.
Based on the survey results, ECDC has made recommendations that should be further developed and implemented across Europe. Increasing the skills for surveillance of healthcare-associated infections and antimicrobial use, and raising awareness of healthcare-associated infections among thousands of healthcare workers across Europe were the main contributions of the point prevalence survey.
Healthcare-associated infections are infections acquired by patients during their stay in a hospital or another healthcare setting. Although some of these infections can be treated easily, others may more seriously affect a patient’s health, increasing their stay in the hospital and hospital costs, and causing considerable distress to these patients. A prevalence survey is a count of the number of patients with a particular condition/treatment (in this case either a healthcare-associated infection or an antimicrobial agent) at a particular time (in this case a day), as a proportion of the total number of patients who are hospitalised at that particular time.
Antimicrobial consumption - Annual Epidemiological Report for 2019
18 Nov 2020 - In 2019, the average total (community and hospital sector combined) consumption of antibacterials for systemic use (Anatomical Therapeutic Chemical (ATC) group J01) in the EU/EEA was 19.4 defined daily doses (DDD) per 1 000 inhabitants per day (country range: 9.5–34.1). During the period 2010–2019, a statistically significant decrease was observed for the EU/EEA overall.
Antimicrobial consumption - Annual Epidemiological Report for 2018
18 Nov 2019 - In 2018, the average total consumption (community and hospital sector combined) of antibacterials for systemic use (ATC group J01) in the EU/EEA was 20.1 DDD per 1 000 inhabitants per day (country range: 9.7–34.0). During the period 2009–2018, no statistically significant change was observed for the EU/EEA overall.